These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26130113)

  • 1. Intestinal Microbiota, Lipids, and the Pathogenesis of Intestinal Failure-Associated Liver Disease.
    Lee WS; Sokol RJ
    J Pediatr; 2015 Sep; 167(3):519-26. PubMed ID: 26130113
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanism of gut-microbiota-liver axis in the pathogenesis of intestinal failure-associated liver disease].
    Fan SX; Wang J; Li Q; Li YS; Guan WX; Li JS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Jan; 24(1):94-100. PubMed ID: 33461259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid emulsions in the treatment and prevention of parenteral nutrition-associated liver disease in infants and children.
    Nandivada P; Fell GL; Gura KM; Puder M
    Am J Clin Nutr; 2016 Feb; 103(2):629S-34S. PubMed ID: 26791189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolving use of intravenous lipid emulsions in the neonatal intensive care unit.
    Calkins KL; Puder M; Gura K
    Semin Perinatol; 2019 Nov; 43(7):151155. PubMed ID: 31331633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of parenteral nutrition-associated liver disease: the role of lipid emulsions.
    Nandivada P; Carlson SJ; Chang MI; Cowan E; Gura KM; Puder M
    Adv Nutr; 2013 Nov; 4(6):711-7. PubMed ID: 24228202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of intravenous fish oil emulsions on pediatric intestinal failure-associated liver disease.
    Venick RS; Calkins K
    Curr Opin Organ Transplant; 2011 Jun; 16(3):306-11. PubMed ID: 21505340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal Failure-Associated Liver Disease.
    Pironi L; Sasdelli AS
    Clin Liver Dis; 2019 May; 23(2):279-291. PubMed ID: 30947877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and treatment of intestinal failure-associated liver disease in children.
    Raphael BP; Duggan C
    Semin Liver Dis; 2012 Nov; 32(4):341-7. PubMed ID: 23397535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric intestinal failure-associated liver disease.
    Courtney CM; Warner BW
    Curr Opin Pediatr; 2017 Jun; 29(3):363-370. PubMed ID: 28333693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parenteral nutrition-associated liver disease and lipid emulsions.
    Zugasti Murillo A; Petrina Jáuregui E; Elizondo Armendáriz J
    Endocrinol Nutr; 2015; 62(6):285-9. PubMed ID: 25982234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of parenteral nutrition-associated liver disease: lipid minimization.
    Cober MP; Teitelbaum DH
    Curr Opin Organ Transplant; 2010 Jun; 15(3):330-3. PubMed ID: 20386446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fish oil emulsions in the management of intestinal failure-associated liver disease.
    Mercer DF
    J Clin Gastroenterol; 2012; 46(10):823-7. PubMed ID: 23060217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver disease after TPN.
    Freund U
    Gastroenterology; 1982 Jan; 82(1):164-5. PubMed ID: 6796455
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms of Parenteral Nutrition-Associated Liver and Gut Injury.
    Madnawat H; Welu AL; Gilbert EJ; Taylor DB; Jain S; Manithody C; Blomenkamp K; Jain AK
    Nutr Clin Pract; 2020 Feb; 35(1):63-71. PubMed ID: 31872510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Hepatotoxicities of Intravenous Fat Emulsions in Infants and Children.
    Nghiem-Rao TH
    Nutr Clin Pract; 2016 Oct; 31(5):619-28. PubMed ID: 27540004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 lipids for intestinal failure associated liver disease.
    Diamond IR; Pencharz PB; Wales PW
    Semin Pediatr Surg; 2009 Nov; 18(4):239-45. PubMed ID: 19782305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil.
    Fallon EM; Le HD; Puder M
    Curr Opin Organ Transplant; 2010 Jun; 15(3):334-40. PubMed ID: 20503524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of gut microbiota in intestinal and liver diseases.
    Hrncir T; Hrncirova L; Kverka M; Tlaskalova-Hogenova H
    Lab Anim; 2019 Jun; 53(3):271-280. PubMed ID: 30580671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paediatric parenteral nutrition and lipid usage in the UK--a pick N' mix situation?
    Flynn DM; Gowen H
    Clin Nutr; 2010 Apr; 29(2):275-6. PubMed ID: 19932534
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenesis and treatment of parenteral nutrition-associated liver disease.
    Xu ZW; Li YS
    Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):586-93. PubMed ID: 23232629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.